Bio-Rad Laboratories (BIO) Net Income towards Common Stockholders (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Net Income towards Common Stockholders of -$527.1 million for Q1 2026, down 923.59% year-over-year from $64.0 million in Q1 2025, and down 173.21% on a QoQ basis from $720.0 million in Q4 2025.
Bio-Rad Laboratories (BIO) has 18 years of Net Income towards Common Stockholders data on file, last reported at -$527.1 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 923.59% year-over-year to -$527.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.8 million (up 107.8% YoY) and the FY2025 annual result came in at $759.9 million, up 141.2% from the prior year.
- Net Income towards Common Stockholders fell to -$527.1 million in Q1 2026 per BIO's latest filing, from $720.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $827.8 million in Q4 2022 and bottomed at -$3.4 billion in Q1 2022.
- The 5-year median for Net Income towards Common Stockholders is $64.0 million (2025), against an average of -$345.7 million.
- The widest annual swing landed in 2024, when Net Income towards Common Stockholders soared 514.75%; it then sank 923.59% in 2026.
- Tracing BIO's Net Income towards Common Stockholders over 5 years: stood at $827.8 million in 2022, then plunged by 57.75% to $349.7 million in 2023, then plunged by 304.67% to -$715.8 million in 2024, then surged by 200.59% to $720.0 million in 2025, then tumbled by 173.21% to -$527.1 million in 2026.
- Per Business Quant, the three latest BIO Net Income towards Common Stockholders figures stand at -$527.1 million (Q1 2026), $720.0 million (Q4 2025), and -$341.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | -527.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -527.10 Mn |
| Dec 31, 2025 | 720.00 Mn |
| Sep 30, 2025 | -341.90 Mn |
| Jun 30, 2025 | 317.80 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | -715.80 Mn |
| Sep 30, 2024 | 653.20 Mn |
| Jun 30, 2024 | -2.17 Bn |
| Mar 31, 2024 | 383.90 Mn |
| Dec 31, 2023 | 349.74 Mn |
| Sep 30, 2023 | 106.26 Mn |
| Jun 30, 2023 | -1.16 Bn |
| Mar 31, 2023 | 68.96 Mn |
| Dec 31, 2022 | 827.81 Mn |
| Sep 30, 2022 | -162.81 Mn |
| Jun 30, 2022 | -925.11 Mn |
| Mar 31, 2022 | -3.37 Bn |
| Dec 31, 2021 | -1.57 Bn |
| Sep 30, 2021 | 3.93 Bn |
| Jun 30, 2021 | 914.14 Mn |
| Mar 31, 2021 | 977.41 Mn |
| Dec 31, 2020 | 847.04 Mn |
| Sep 30, 2020 | 1.31 Bn |
| Jun 30, 2020 | 966.43 Mn |
| Mar 31, 2020 | 685.91 Mn |
| Dec 31, 2019 | 553.44 Mn |
| Sep 30, 2019 | -258.82 Mn |
| Jun 30, 2019 | 598.81 Mn |
| Mar 31, 2019 | 865.20 Mn |
| Dec 31, 2018 | -828.49 Mn |
| Sep 30, 2018 | 269.30 Mn |
| Jun 30, 2018 | 268.04 Mn |
| Mar 31, 2018 | 656.79 Mn |
| Dec 31, 2017 | 82.70 Mn |
| Sep 30, 2017 | 22.07 Mn |
| Jun 30, 2017 | 5.04 Mn |
| Mar 31, 2017 | 12.37 Mn |
| Dec 31, 2016 | -18.64 Mn |
| Sep 30, 2016 | 17.10 Mn |
| Jun 30, 2016 | 16.60 Mn |
| Mar 31, 2016 | 11.00 Mn |
| Dec 31, 2015 | 45.64 Mn |
| Sep 30, 2015 | 17.37 Mn |
| Jun 30, 2015 | 28.42 Mn |
| Mar 31, 2015 | 17.82 Mn |
| Dec 31, 2014 | 39.05 Mn |
| Sep 30, 2014 | 11.51 Mn |
| Jun 30, 2014 | 31.63 Mn |
| Mar 31, 2014 | 6.67 Mn |
| Dec 31, 2013 | 30.14 Mn |
| Sep 30, 2013 | -7.10 Mn |
| Jun 30, 2013 | 34.60 Mn |
| Mar 31, 2013 | 20.17 Mn |
| Dec 31, 2012 | 42.64 Mn |
| Sep 30, 2012 | 42.02 Mn |
| Jun 30, 2012 | 47.96 Mn |
| Mar 31, 2012 | 30.55 Mn |
| Dec 31, 2011 | 59.55 Mn |
| Sep 30, 2011 | 45.37 Mn |
| Jun 30, 2011 | 39.94 Mn |
| Mar 31, 2011 | 31.74 Mn |
| Dec 31, 2010 | 64.11 Mn |
| Sep 30, 2010 | 40.79 Mn |
| Jun 30, 2010 | 20.92 Mn |
| Mar 31, 2010 | 35.39 Mn |
| Dec 31, 2009 | 19.04 Mn |
| Sep 30, 2009 | 39.30 Mn |
| Jun 30, 2009 | 59.25 Mn |